SCHEMBL20042814

SCHEMBL20042814

O=C(C1CCC1)N1Cc2nc(-c3cccnc3)nc(N3CCC3)c2C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFTR P13569 3/20 0.52
ALDH1A1 P00352 2/20 0.45
USP2 O75604 1/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
TSHR P16473 1/20 0.45
MAPK1 P28482 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
HSD17B10 Q99714 1/20 0.45
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
GBA1 P04062 8/20 0.41
PDE10A Q9Y233 3/20 0.41
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
ALOX15 P16050 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20042924 0.82 CNR2 (0.58) CFTRTSHRMEN1KMT2A
SCHEMBL20042801 0.82 CFTR (0.51) CFTRLMNATSHRMAPK1MEN1
SCHEMBL20042825 0.81 GBA1 (0.61) CFTRALDH1A1USP2LMNAMAPT
SCHEMBL20042800 0.76 CNR1 (0.45) ALDH1A1LMNAMAPTTSHRMEN1
SCHEMBL20042799 0.76 ALDH1A1 (0.36) ALDH1A1LMNAMAPTTSHRMEN1
SCHEMBL20608463 0.73 ALDH1A1 (0.55) CFTRALDH1A1USP2LMNAMAPT
SCHEMBL29710079 0.73 ALDH1A1 (0.55) CFTRALDH1A1USP2LMNAMAPT
SCHEMBL20042806 0.73 CNR1 (0.47) ALDH1A1LMNAMAPTTSHRNPSR1
SCHEMBL20042764 0.72 CNR1 (0.49) ALDH1A1LMNAMAPTTSHRNPSR1
SCHEMBL20042709 0.72 ALDH1A1 (0.53) CFTRALDH1A1USP2LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018066718-A1 THERAPEUTIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-04-12 WO disclosed